Johnson & Johnson will acquire Ollin for $2.2 ‌billion upfront, with the potential for milestone payments of up to about ...
It's a constant dull ache which turns into a throbbing pain if I use my arm for anything like washing the car. What advice ...
The deal hands J&J a treatment that could complement its existing eye care franchise, but would vie for share of a crowded and competitive market. Backed by Arch Venture Partners and TCGX, among ...
An optogenetic therapy helped patients with retinitis pigmentosa maintain vision gains through 4 years, according to a study ...
Children with amblyopia treated with Luminopia had stable visual acuity and a low rate of recurrence up to a year after ...